While we did not find evidence of PCK2 upregulation in our mCRC model, three recent studies demonstrated that PCK2 upregulation in lung cancer cells in vitro can improve cancer cell survival in glucose-depleted conditions (Leithner et al., 2015; Vincent et al., 2015). The gene discussed is PCK2; the disease is cancer.